EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Generation of a genetically double-attenuated Plasmodium berghei parasite that fully arrests growth during late liver stage development

Melanie Schmid, Raphael Beyeler, Reto Caldelari, Ruth Rehmann, Volker Heussler iD, Magali Roques iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0316164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Melanie Schmid und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cell Biology, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Plasmodium berghei, Liver, Malaria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Multidisciplinary Center for Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria caused by Plasmodium parasites remains a large health burden. One approach to combat this disease involves vaccinating individuals with whole sporozoites that have been genetically modified to arrest their development at a specific stage in the liver by targeted gene deletion, resulting in a genetically attenuated parasite (GAP). Through a comprehensive phenotyping screen, we identified the hscb gene, encoding a putative iron-sulfur protein assembly chaperone, as crucial for liver stage development, making it a suitable candidate gene for GAP generation. Parasites lacking Plasmodium berghei HscB ( Pb HscB) exhibited normal sporozoite production in mosquitoes, but their liver stage development was severely impaired, characterized by slow growth and delayed expression of merozoite surface protein 1 (MSP1). In vivo experiments demonstrated that Pb HscB-deficient parasites exhibited a delay in prepatency of 2–4 days, emphasizing the significance of Pb HscB for exo-erythrocytic development. Although knockout of Pb HscB alone allowed breakthrough infections, it is a potent candidate for a dual gene deletion strategy. PlasMei2, an RNA-binding protein, was previously found to be crucial for the completion of liver stage development. We generated a Pb HscB- Pb Mei2-double attenuated parasite line, serving as a late liver stage-arresting replication-competent (LARC) GAP, providing a solid block of liver-to-blood stage transition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium bergheiLiverMalariaAnimalsMiceSporozoitesProtozoan ProteinsFemaleAnophelesMice, Inbred C57BLMerozoite Surface Protein 1Gene Deletion

Substanzen

Protozoan ProteinsMerozoite Surface Protein 1

Autor:innen und Institutionen

  • Institute of Cell Biology, University of Bern, Bern, Switzerland.
  • Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.

ORCID-Profile: Volker Heussler, Magali Roques

Förderung

  • Swiss National Science Foundation
  • Multidisciplinary Center for Infectious Diseases

Zitieren

APA

Schmid, M., Beyeler, R., Caldelari, R., Rehmann, R., Heussler, V., & Roques, M. (2024). Generation of a genetically double-attenuated Plasmodium berghei parasite that fully arrests growth during late liver stage development. PLOS ONE. https://doi.org/10.1371/journal.pone.0316164

Vancouver

Schmid M, Beyeler R, Caldelari R, Rehmann R, Heussler V, Roques M. Generation of a genetically double-attenuated Plasmodium berghei parasite that fully arrests growth during late liver stage development. PLOS ONE. 2024. doi:10.1371/journal.pone.0316164

BibTeX
@article{Schmid2024,
  author = {Schmid, Melanie and Beyeler, Raphael and Caldelari, Reto and Rehmann, Ruth and Heussler, Volker and Roques, Magali},
  title = {Generation of a genetically double-attenuated Plasmodium berghei parasite that fully arrests growth during late liver stage development},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0316164}
}
Kostenlos starten →